(ADMA) ADMA Biologics - Performance 232.3% in 12m
Compare ADMA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
79.03%
#5 in Group
Rel. Strength
98.99%
#82 in Universe
Total Return 12m
232.26%
#3 in Group
Total Return 5y
583.33%
#3 in Group
P/E 26.3
67th Percentile in Group
P/E Forward 29.0
77th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 2.19%
93th Percentile in Group
12m Total Return: ADMA (232.3%) vs XBI (-6.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
| GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: ADMA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ADMA
| Total Return (including Dividends) | ADMA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.94% | -10.94% | -6.73% |
| 3 Months | 31.06% | -14.92% | -11.93% |
| 12 Months | 232.26% | -6.46% | 7.24% |
| 5 Years | 583.33% | -19.21% | 100.61% |
| Trend Score (consistency of price movement) | ADMA | XBI | S&P 500 |
| 1 Month | 33.6% | -52.8% | -63.5% |
| 3 Months | 80.6% | -92.8% | -90.3% |
| 12 Months | 67.2% | -32.4% | 60.6% |
| 5 Years | 81.1% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #29 | 20.1% | 14.7% |
| 3 Month | #8 | 54.1% | 48.8% |
| 12 Month | #3 | 255% | 210% |
| 5 Years | #3 | 746% | 241% |
FAQs
Does ADMA ADMA Biologics outperforms the market?
Yes,
over the last 12 months ADMA made 232.26%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months ADMA made 31.06%, while XBI made -14.92%.
Over the last 3 months ADMA made 31.06%, while XBI made -14.92%.
Performance Comparison ADMA vs Indeces and Sectors
ADMA vs. Indices ADMA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.50% | 13.7% | 45.3% | 225% |
| US NASDAQ 100 | QQQ | 0.02% | 14.3% | 45.1% | 225% |
| US Dow Jones Industrial 30 | DIA | 2.53% | 13.9% | 44.7% | 228% |
| German DAX 40 | DAX | -0.72% | 10.9% | 25.4% | 212% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.07% | 10.3% | 44.1% | 223% |
| Hongkong Hang Seng | HSI | -2.17% | 10.7% | 40.7% | 215% |
| India NIFTY 50 | INDA | -1.65% | 4.91% | 41.9% | 229% |
| Brasil Bovespa | EWZ | -3.77% | 6.48% | 40.2% | 241% |
ADMA vs. Sectors ADMA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.21% | 13.8% | 36.1% | 217% |
| Consumer Discretionary | XLY | -0.94% | 13.8% | 40.0% | 221% |
| Consumer Staples | XLP | 0.35% | 3.96% | 37.3% | 221% |
| Energy | XLE | 0.43% | 19.4% | 46.6% | 245% |
| Financial | XLF | -0.20% | 11.8% | 36.4% | 214% |
| Health Care | XLV | 2.77% | 14.7% | 47.5% | 235% |
| Industrial | XLI | 1.10% | 13.0% | 45.4% | 228% |
| Materials | XLB | 0.76% | 12.8% | 52.5% | 238% |
| Real Estate | XLRE | 0.73% | 10.2% | 45.6% | 218% |
| Technology | XLK | 0.23% | 15.9% | 51.5% | 231% |
| Utilities | XLU | 0.61% | 6.74% | 41.6% | 211% |
| Aerospace & Defense | XAR | 1.95% | 10.1% | 35.9% | 210% |
| Biotech | XBI | -2.92% | 17.9% | 56.7% | 239% |
| Homebuilder | XHB | -1.03% | 15.1% | 60.0% | 243% |
| Retail | XRT | -1.37% | 12.3% | 48.7% | 239% |